Skip to content

Covid-19 Patients Management During Home Isolation

Covid-19 Patients Management During Home Isolation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04945564
Enrollment
60
Registered
2021-06-30
Start date
2021-06-30
Completion date
2021-08-31
Last updated
2021-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The study will investigate management of Covid-19 patients in home isolation.

Detailed description

A clinical trial concerned with the treatment of home isolated COVID-19 patients

Interventions

PROCEDUREOxygen therapy and physical therapy

Patients receive oxygen therapy and physical therapy

DEVICEOxygen therapy

Patients receive oxygen therapy

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* Covid-19 patients American Society of Anesthesiologists (ASA) class I \>= 21 years old \<= 40 years old

Exclusion criteria

* Not being consistent with home-isolation regimen

Design outcomes

Primary

MeasureTime frameDescription
Time for recovery of pH24 hoursAcidity Potential Hydrogen
Time for recovery of PaO224 hoursPartial Pressure of Oxygen
Time for recovery of PaCO224 hoursPartial Pressure of Carbon Dioxide
Chest CT scanBaselineChest computed tomography scan

Secondary

MeasureTime frameDescription
Time for recovery of Temperature24 hoursvital sign
Time for recovery of Blood Pressure24 hoursvital sign
Time for recovery of Respiratory Rate24 hoursvital sign
Time for recovery of Oxygen Saturation24 hoursvital sign
Time for recovery of Heart Rate24 hoursvital sign

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026